Voyager Q3 FY26: Record Bookings and Revenue; FY26 Guidance Raised

What happened

Voyager reported Q3 FY26 results with record bookings of $116 million (up 135% YoY) and revenue growth of 124% YoY and 68% QoQ. The company also raised its full-year fiscal 2026 revenue outlook, signaling stronger-than-expected demand across its defense, national security, and space programs. This performance directly addresses a key concern from the prior deep value report: the ability to convert backlog into recognized revenue and replace expiring NASA services work. While the press release emphasizes growth, it does not disclose profitability metrics, and Voyager remains a loss-making company with management having previously guided to multi-year net losses and increasing operating expenses. The raised guidance suggests the company is on track to exceed the upper end of the prior $225–255 million FY26 revenue range, but investors must still assess cash burn and any fresh financing needs.

Implication

Investors should interpret the raised guidance as evidence that defense and space program ramps are converting to revenue faster than previously modeled, which may warrant a re-rating of the stock away from the prior 'potential sell' stance. However, the market will need to see sustained quarters of high revenue growth accompanied by narrowing operating losses before the investment case shifts from dilution-driven risk to fundamental value. The record bookings of $116 million (a 135% YoY increase) suggest funded backlog likely expanded, which directly alleviates one of the master report's key bear scenarios. Still, the absence of profit details in the earnings call summary leaves open the question of whether this growth is margin-accretive or simply more revenue at similar loss rates. Until management demonstrates a clear path to positive operating cash flow, a cautious stance remains prudent, with the stock likely to remain volatile around contract headlines.

Thesis delta

The prior thesis rated VOYG as a potential sell at $30.10, predicated on weak evidence of backlog conversion and a high probability of future dilution given multi-year losses and elevated spending. The Q3 results and guidance raise directly counter that narrative by showing revenue growing 124% YoY and bookings up 135%, suggesting funded backlog is converting at an accelerating pace. While the thesis shifts from bearish to neutral-to-positive on the revenue trajectory, the profitability and capital structure risks remain unresolved, so we would upgrade the rating from potential sell to hold with a revised entry point near $24–26 if the stock pulls back.